MedLife, the leader of the private medical services market in Romania, announces its entrance in a new business segment with the start of the process of taking over the majority shares package of the Stem Cells Bank based in Timisoara, one of the most modern and well-equipped stem cells banks in South-East Europe.
This is the second transaction initiated by MedLife this year, following its takeover of 55 per cent of the Centrul Medical SAMA and Ultratest group of companies in Oltenia. The Stem Cells Bank is active in Bucharest and Timisoara, the latter being the location of its storage bank.
Following the transaction, MedLife will own the majority shares package while the Bank’s current shareholders will own the minority shares package and will continue to manage the company.
The Stem Cells Bank was inaugurated in 2010 in Timisoara and is the stem cells bank with the most modern processing system in Romania, a system based on the Biosafe Sepax 2 technology, and at the same time the only private stem cells bank in the Balkans that uses this technology which ensures fully automated processing and isolation of stem cells, thus eliminating any risk of laboratory contamination.
MedLife is active in Romania since 1996, being the largest private operator of medical services on the local market. The company covers all areas of medical activity: outpatient services, hospitals, maternities, laboratories, pharmacies, all of which make up the MedLife Medical System.
